Abstract
Isomorphic Labs, the Al drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with participation from GV, and existing investor Google's parent Alphabet, it said.
Key Data
-
Publication Date31 March 2025
-
Primary AuthorMarina Temkin
-
SourceTechCrunch
-
LanguageEnglish
Click below to visit original source: